4.2 Article

A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell Responses In Vivo

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity

C. Trumpfheller et al.

JOURNAL OF INTERNAL MEDICINE (2012)

Review Oncology

Cancer immunotherapy via dendritic cells

Karolina Palucka et al.

NATURE REVIEWS CANCER (2012)

Review Pharmacology & Pharmacy

The immunogenicity of CpG-antigen conjugates

Hermann Wagner

ADVANCED DRUG DELIVERY REVIEWS (2009)

Article Medicine, Research & Experimental

Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin

David Sancho et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Review Immunology

Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting

Paul J. Tacken et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Article Immunology

Antigenic targeting of the human mannose receptor induces tumor immunity

Li-Zhen He et al.

JOURNAL OF IMMUNOLOGY (2007)

Article Immunology

On regulation of phagosome maturation and antigen presentation

J. Magarian Blander et al.

NATURE IMMUNOLOGY (2006)

Article Biochemical Research Methods

A monovalent streptavidin with a single femtomolar biotin binding site

M Howarth et al.

NATURE METHODS (2006)

Review Multidisciplinary Sciences

Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance

RM Steinman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Immunology

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

D Hawiger et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2001)